BetterLife Pharma Files July 2024 6-K Report
Ticker: BETRF · Form: 6-K · Filed: Sep 26, 2024 · CIK: 1464165
Sentiment: neutral
Topics: reporting, foreign-private-issuer, routine-filing
Related Tickers: BETRF
TL;DR
BetterLife Pharma (BETRF) filed its July 6-K, just a routine check-in, no big news.
AI Summary
BetterLife Pharma Inc. filed a Form 6-K for the month of July 2024, reporting as a foreign private issuer. The company, formerly known as Pivot Pharmaceuticals Inc. and Neurokine Pharmaceuticals Inc., is incorporated in A1 and has its principal executive office in Vancouver, BC, Canada. This filing is routine and does not contain specific financial or operational updates beyond its periodic reporting status.
Why It Matters
This filing indicates BetterLife Pharma Inc. is meeting its periodic reporting obligations as a foreign private issuer with the SEC. It does not contain new material information but confirms ongoing compliance.
Risk Assessment
Risk Level: low — This is a routine filing confirming the company's reporting status and does not contain new material financial or operational information.
Key Players & Entities
- BetterLife Pharma Inc. (company) — Filer
- Pivot Pharmaceuticals Inc. (company) — Former Company Name
- Neurokine Pharmaceuticals Inc. (company) — Former Company Name
- 20240731 (date) — Period of Report
- 20240926 (date) — Filing Date
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information that BetterLife Pharma Inc. has made or is required to make public in Canada, or has filed or is required to file with any stock exchange on which its securities are traded. It serves as a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
What period does this Form 6-K cover?
This Form 6-K filing covers the month of July 2024, with the 'Conformed Period of Report' listed as 20240731.
What are the former names of BetterLife Pharma Inc.?
BetterLife Pharma Inc. was formerly known as Pivot Pharmaceuticals Inc. (name change on 20150417) and prior to that, Neurokine Pharmaceuticals Inc. (name change on 20090514).
Where is BetterLife Pharma Inc. headquartered?
BetterLife Pharma Inc.'s principal executive office is located at 1275 West 6th Avenue, #300, Vancouver, BC, Canada V6H 1A6.
Does this filing indicate any new financial results or material business developments?
No, this filing is a routine Form 6-K for the month of July 2024 and does not appear to contain specific new financial results or material business developments beyond its status as a periodic report.
Filing Stats: 349 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2024-09-26 06:00:38
Filing Documents
- betrf_6k.htm (6-K) — 11KB
- betrf_ex991.htm (EX-99.1) — 203KB
- betrf_ex992.htm (EX-99.2) — 683KB
- betrf_ex993.htm (EX-99.3) — 7KB
- betrf_ex994.htm (EX-99.4) — 8KB
- betrf_ex991img1.jpg (GRAPHIC) — 4KB
- 0001477932-24-005941.txt ( ) — 919KB
Management's discussion and analysis
Management's discussion and analysis 99.2
Financial statements
Financial statements 99.3 CEO certification 99.4 CFO certification 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934 , the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BETTERLIFE PHARMA INC. Date: September 25, 2024 By: /s/ Moira Ong Name: Moira Ong Title: Chief Financial Officer 3